Home › Funds › RA CAPITAL MANAGEMENT, L.P. › VOR

RA CAPITAL MANAGEMENT, L.P. position in VOR

VOR BIOPHARMA INC · Health Care

RA CAPITAL MANAGEMENT, L.P. reported holding 4,503,882 shares of VOR (VOR BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$85.9M, representing 0.88% of its reported portfolio and ranking #24 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed VOR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)4.50M sh
Reported value held$85.93M
Portfolio Weight0.88%
First reportedQ3 2023
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How RA CAPITAL MANAGEMENT, L.P.'s VOR position evolved

RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in VOR in Q3 2023 at 22,748,880 shares (US$48.2M). The position peaked in Q3 2025 at 1,982,301 shares, worth US$96.6M. Across 13 filings, RA CAPITAL MANAGEMENT, L.P. increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 4,503,882 shares valued at US$85.9M — an increase of 2,101,787 shares quarter over quarter.. Notable position changes include a 95% trim in Q3 2025 (shares fell 73% over the following quarter), a 173% increase in Q4 2025 (shares rose 36% over the following quarter), a 87% increase in Q3 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 22.75M $48.23M New
Q4 2023 22.75M $51.18M Hold
Q1 2024 22.75M $53.91M Hold
Q2 2024 22.75M $22.75M Hold
Q3 2024 22.75M $15.92M Hold
Q4 2024 39.65M $44.01M Add
Q1 2025 39.65M $28.45M Hold
Q2 2025 39.65M $64.23M Hold
Q3 2025 1.98M $96.58M Reduce
Q4 2025 5.40M $70.70M Add
Q1 2026 5.40M $96.43M Hold
Q2 2026 2.40M $44.22M Reduce
Q3 2026 4.50M $85.93M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VOR and 13F data

VOR (VOR BIOPHARMA INC) is a Health Care company. 70 other funds we track also report a position in VOR — the largest reported positions include TCG Crossover Management, LLC (US$108.2M), FCPM III SERVICES B.V. (US$65.0M), Venrock Adviser, LLC (US$58.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VOR

All VOR fund holders →

FAQ

How long has RA CAPITAL MANAGEMENT, L.P. held VOR?

RA CAPITAL MANAGEMENT, L.P. has disclosed VOR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is RA CAPITAL MANAGEMENT, L.P.'s current position in VOR?

As of Q3 2026, RA CAPITAL MANAGEMENT, L.P. holds 4.50M shares of VOR (VOR BIOPHARMA INC), valued at $85.93M, representing 0.88% of its reported portfolio and ranking #24.

Has RA CAPITAL MANAGEMENT, L.P. been buying or selling VOR?

In the latest 13F filing (Q3 2026), RA CAPITAL MANAGEMENT, L.P. increased its position in VOR. The position peaked in Q3 2025 at 1.98M shares.

Which other funds hold VOR?

Other major institutional holders of VOR include TCG Crossover Management, LLC, FCPM III SERVICES B.V., Venrock Adviser, LLC, among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.